As of 2025-05-05, the Fair Value of BioCardia Inc (BCDA) is -18.23 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.68 USD, the upside of BioCardia Inc is -780.36%.
With the market price of 2.68 USD and our fair value calculation, BioCardia Inc (BCDA) is not a good investment. Investing in BCDA stocks now will result in a potential loss of 780.36%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -15.00 | -12.62 | -11.91 | -11.57 | -7.95 | -11.81 |
| YoY growth | -1.97% | 15.87% | 5.63% | 2.85% | 31.33% | 10.74% |
| Market Cap (mil) | 12.54 |
| P/E | |
| Forward P/E |
| EPS | -1.70 |
| Avg earnings growth rate | 10.74% |
| TTM earnings | -7.95 |